A single arm, multicenter, phase II trial of oxaliplatin plus capecitabine in the perioperative treatment of locally advanced gastric adenocarcinoma in combination with D2 gastrectomy (NEO-CLASSIC)

被引：0
|
作者：
Tianshu, L. [1 ]
Yu, Y. [1 ]
Sun, Y. [2 ]
Min, Y. [3 ]
Cao, H. [4 ]
Yingbin, L. [5 ]
Wang, Y. [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Med Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, Dept Gen Surg, Coll Med, Shanghai, Peoples R China
[4] Shanghai Renji Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Gen Surg, Sch Med, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
229P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Optimal regimen of trastuzumab in combination with oxaliplatin/capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial
    Gong, Jifang
    Liu, Tianshu
    Fan, Qingxia
    Bai, Li
    Bi, Feng
    Qin, Shukui
    Wang, Jinwan
    Xu, Nong
    Cheng, Ying
    Bai, Yuxian
    Liu, Wei
    Wang, Liwei
    Shen, Lin
    BMC CANCER, 2016, 16
  • [42] Efficacy and safety of S-1 plus oxaliplatin combined with apatinib and camrelizumab as neoadjuvant therapy for patients with locally advanced gastric or gastroesophageal junction adenocarcinoma: a protocol for a single-arm phase II trial
    Chang, Chen
    Cai, Zhaolun
    Cheng, Ke
    Shen, Chaoyong
    Zhang, Bo
    Chen, Zhixin
    Yin, Yuan
    Cao, Dan
    UPDATES IN SURGERY, 2025, 77 (01) : 165 - 174
  • [43] Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial
    Jifang Gong
    Tianshu Liu
    Qingxia Fan
    Li Bai
    Feng Bi
    Shukui Qin
    Jinwan Wang
    Nong Xu
    Ying Cheng
    Yuxian Bai
    Wei Liu
    Liwei Wang
    Lin Shen
    BMC Cancer, 16
  • [44] Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
    Al-Batran, Salah-Eddin
    Homann, Nils
    Pauligk, Claudia
    Goetze, Thorsten O.
    Meiler, Johannes
    Kasper, Stefan
    Kopp, Hans-Georg
    Mayer, Frank
    Haag, Georg Martin
    Luley, Kim
    Lindig, Udo
    Schmiegel, Wolff
    Pohl, Michael
    Stoehlmacher, Jan
    Folprecht, Gunnar
    Probst, Stephan
    Prasnikar, Nicole
    Fischbach, Wolfgang
    Mahlberg, Rolf
    Trojan, Joerg
    Koenigsmann, Michael
    Martens, Uwe M.
    Thuss-Patience, Peter
    Egger, Matthias
    Block, Andreas
    Heinemann, Volker
    Illerhaus, Gerald
    Moehler, Markus
    Schenk, Michael
    Kullmann, Frank
    Behringer, Dirk M.
    Heike, Michael
    Pink, Daniel
    Teschendorf, Christian
    Loehr, Carmen
    Bernhard, Helga
    Schuch, Gunter
    Rethwisch, Volker
    von Weikersthal, Ludwig Fischer
    Hartmann, Joerg T.
    Kneba, Michael
    Daum, Severin
    Schulmann, Karsten
    Weniger, Joerg
    Belle, Sebastian
    Gaiser, Timo
    Oduncu, Fuat S.
    Guentner, Martina
    Hozaeel, Wael
    Reichart, Alexander
    LANCET, 2019, 393 (10184): : 1948 - 1957
  • [45] Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial
    Jie Shen
    Beibei Cao
    Yatao Wang
    Aitang Xiao
    Jichao Qin
    Jianhong Wu
    Qun Yan
    Yuanlong Hu
    Chuanyong Yang
    Zhixin Cao
    Junbo Hu
    Ping Yin
    Daxing Xie
    Jianping Gong
    Trials, 19
  • [46] Perioperative sintilimab combination with SOX for resectable locally advanced gastric/gastroesophageal junction cancer(GC/GEJC): Initial findings of a single-arm phase II trial
    Ding, Xuewei
    Li, Bin
    Xue, Qiang
    Cai, Mingzhi
    Cui, Jingli
    Wang, Baogui
    Ke, Bin
    Zhang, Rupeng
    Liang, Han
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [47] Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II-III randomized trial
    Xue, Kan
    Ying, Xiangji
    Bu, Zhaode
    Wu, Aiwen
    Li, Zhongwu
    Tang, Lei
    Zhang, Lianhai
    Zhang, Yan
    Li, Ziyu
    Ji, Jiafu
    CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (05) : 516 - +
  • [48] Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
    Shi, Jinming
    Li, Ning
    Tang, Yuan
    Jiang, Liming
    Yang, Lin
    Wang, Shulian
    Song, Yongwen
    Liu, Yueping
    Fang, Hui
    Lu, Ningning
    Qi, Shunan
    Chen, Bo
    Li, Ziyu
    Liu, Shixin
    Wang, Jun
    Wang, Wenling
    Zhu, Suyu
    Yang, Jialin
    Li, Yexiong
    Zhao, Dongbing
    Jin, Jing
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [49] Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
    Jinming Shi
    Ning Li
    Yuan Tang
    Liming Jiang
    Lin Yang
    Shulian Wang
    Yongwen Song
    Yueping Liu
    Hui Fang
    Ningning Lu
    Shunan Qi
    Bo Chen
    Ziyu Li
    Shixin Liu
    Jun Wang
    Wenling Wang
    Suyu Zhu
    Jialin Yang
    Yexiong Li
    Dongbing Zhao
    Jing Jin
    BMC Gastroenterology, 22
  • [50] Intraperitoneal paclitaxel with systemic S-1 plus oxaliplatin for advanced or recurrent gastric cancer with peritoneal metastasis: A single-arm, multicenter phase II clinical trial
    Seo, Won Jun
    Kim, Dong-Wook
    Lee, Chang Min
    Park, Ji Yeon
    Jang, You-Jin
    Park, Joong-Min
    Kim, Jong Won
    Jee, Ye Seob
    Choi, Sung Il
    Oh, Sang Chul
    Kim, Jong-Han
    EJSO, 2025, 51 (06):
12345